About this Journal
Aims and scope
Cardiovascular Therapeutics(formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
- Acute coronary syndrome
- Arrhythmias
- Atherosclerosis
- Basic cardiac electrophysiology
- Cardiac catheterization
- Cardiac remodeling
- Coagulation and thrombosis
- Diabetic cardiovascular disease
- Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
- Hyperlipidemia
- Hypertension
- Ischemic heart disease
- Vascular biology
- Ventricular assist devices
- Molecular cardio-biology
- Myocardial regeneration
- Lipoprotein metabolism
- Radial artery access
- Percutaneous coronary intervention
- Transcatheter aortic and mitral valve replacement
The Wiley Hindawi Partnership
This journal is published by Hindawi as part of a publishing collaboration with约翰会ey & Sons, Inc.It is a fully Open Access journal produced under the Hindawi and Wiley brands.
Bibliographic information
ISSN: 1755-5914 (Print)
ISSN: 1755-5922 (Online)
DOI: 10.1155/4702
Archival content
Content published prior to 2019 is hosted on theWiley Online Library.
Open Access
Cardiovascular Therapeuticsis an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on ourcopyright page.
Contact
Editorial enquiries should be directed tocdtp@hindawi.com.
General enquiries should be directed tohelp@hindawi.com.
